Christian Behrenbruch Insider Profile
4 Followers
Christian Behrenbruch, Managing Director & Chief Executive Officer at Telix Pharmaceuticals, holds 21.40M shares in Telix Pharmaceuticals (Ticker: TLPPF), holds 2.74M shares in Amplia Therapeutics (Ticker: INNMF), holds 3.27M shares in Dominion Minerals Limited (Ticker: DE:1TT). Most recently, Christian Behrenbruch Bought ― shares of Telix Pharmaceuticals on Apr 30, 2026 for an estimated value of $996.70K.
Christian Behrenbruch Telix Pharmaceuticals (TLPPF)Managing Director & Chief Executive Officer
Telix Pharmaceuticals (TLPPF)
Managing Director & Chief Executive Officer
Ranked #7,247 out of 109,030 Corporate Insiders
Profitable Transactions
4 out of 5 Profitable Transactions
Average Return
+59.30%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Christian Behrenbruch holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Sep 17, 2019 - Sep 17, 2020
Return:+133.30%
The most profitable trade made by Christian Behrenbruch
Christian Behrenbruch's Trading History
Telix Pharmaceuticals
Apr 30, 2026
Managing Director & Chief Executive Officer
Informative Buy
996.70K
$256.76M
Dominion Minerals Limited
Apr 24, 2018
Executive
Informative Buy
16.33K
€52.24K
Amplia Therapeutics
Sep 17, 2019
Director
Informative Buy
25.00K
$246.79K
List of latest transactions for each holding click on a transaction to see Christian Behrenbruch's performance on stock
You May Also Like
Christian Behrenbruch insider profile FAQ
What is the percentage of profitable transactions made by Christian Behrenbruch?
The percentage of profitable transactions made by Christian Behrenbruch is 80%.
What is the average return per transaction made by Christian Behrenbruch?
The average return per transaction made by Christian Behrenbruch is 59.30%.
What stocks does Christian Behrenbruch hold?
Christian Behrenbruch holds: TLPPF, DE:1TT, INNMF stocks.
What was Christian Behrenbruch’s latest transaction?
Christian Behrenbruch latest transaction was an Informative Buy of $996.70K.
What was Christian Behrenbruch's most profitable transaction?
Christian Behrenbruch’s most profitable transaction was an Informative Buy of INNMF stock on September 17, 2019. The return on the trade was 133.30%.
What is Christian Behrenbruch's role in Telix Pharmaceuticals?
Christian Behrenbruch's role in Telix Pharmaceuticals is Managing Director & Chief Executive Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.